STVN · Stevanato Group S.p.A.

Track STVN — free

$19.77 -0.28 (-1.40%)

Rebalance outlook locked

Market Cap

$5.77B

273.00M

Volume · Oct 6 62.85K Avg daily vol (3M) 372.2K

Up next

Next earnings call

Nov 22, 2026 Est · unconfirmed · in 7 wks

Q2 2026 earnings call transcript

call held Aug 4, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

—

Trailing 12 months

Net income (TTM)

—

Trailing 12 months

Revenue growth YoY

+7.4%

Year over year

Operating margin

16.8%

Trailing 12 months

P / E (TTM)

—

Trailing earnings

FCF yield

—

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+0.0%

Year over year

Price change (1Y)

-23.5%

Trailing year

Short interest

0.4%

Latest settlement · 4.0 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Sell

SellHoldBuy

Technical Neutral Momentum Strong Sentiment Bearish Fundamentals Limited Quant / Vol Very High

Market backdrop VIX 15.5 · calm Equity put/call 0.59

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg +10%

above

Price vs 50-day avg −5%

below

RSI (14) 39

neutral

MACD trend Negative

52-week position 47%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Strong

1-month return −2%

trailing

6-month return +36%

trailing

YTD return 0%

this year

Relative strength +24%

vs S&P · 6-mo

Sentiment

smart money

Bearish

Trend (MA cross) No cross

50d $21 › 200d $18 — 50d above 200d

Institutional flow Distributing

2 of 125 funds reported for Sep 30 · net -31.2K sh shares

Insider flow Distributing

Net -$459.7K over 90 days · 100% sells

Short interest Rising

0.43% of float · ▲ +5.4% MoM · 4.0 days cover

Volume signal Reversal watch

High volume on a down day — possible exhaustion

Institution breadth Steady

125 holders — mid 3-yr range

Squeeze score 41

elevated · 0–100

Fundamentals

Limited

Not enough data for a confident read.

Quant / Vol

risk profile

Very High

Volatility 47%

annualized · 1-yr

Max drawdown −51%

past year

ATR 4.2%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the Earnings Call filed Jun 30, 2026

fiscal year 2026

High-value solutions as % of total company revenue Initiated 47% – 48%

fiscal 2026

High-value solutions as percent of total company revenue Initiated 47% – 48%

Adjusted EBITDA margin Non-GAAP Initiated 26.8%

full year

Adjusted EBITDA margin Non-GAAP 26.8%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral

1 · 5 · 1

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+10% Bullish

Price vs 50-day avg

−5% Neutral

RSI (14)

39 Neutral

MACD trend

Negative Bearish

52-week position

47% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bearish · 3 of 6

Trend (MA cross) No cross

50d $21 › 200d $18 — 50d above 200d

Institutional flow Distributing

2 of 125 funds reported for Sep 30 · net -31.2K sh shares

Insider flow Distributing

Net -$459.7K over 90 days · 100% sells

Short interest Rising

0.43% of float · ▲ +5.4% MoM · 4.0 days cover

Volume signal Reversal watch

High volume on a down day — possible exhaustion

Institution breadth Steady

125 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $13 Now $20 · 47% Range high $28

vs 200-day avg +10% vs 50-day avg -5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Instruments & Supplies — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
STVN Stevanato Group S.p.A. this stock	$5.77B	-0.3%	—	—	0.4%
ISRG Intuitive Surgical Inc	$143.14B	-28.2%	+20.5%	46.5	2.3%
BDX Becton Dickinson & Co	$49.57B	—	+8.2%	—	4.2%
MDLN Medline Inc.	$45.62B	-14.8%	+11.5%	—	3.1%
RMD Resmed Inc	$32.02B	-7.5%	+13.4%	21.3	9.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

125

% held: 16.4%
Reported: 2 of 125
Top holder: Conestoga Capital Advisor…

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Rising

Shares short

1.2M

Days to cover: 4.0d
Change: +60.7K sh

View

Short Volume

Short vol %

25%

As of: Oct 5, 2026

Short Total

View

Fails to Deliver

FTD shares

124

Value: $2.6K
As of: Sep 14, 2026

View

Off-Exchange

Off-exchange %

30.1%

Week of: Aug 31, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$459.7K

Buyers / Sellers: 0 / 4

Buyers Sellers

View

Filings

SEC Filings

Latest

Investor Event Transcript

Filed: Sep 15, 2026
This year: 18

View

Proposed Sales

Value

$276.3K

Shares: 13.6K
Filed: Sep 14, 2026

View

Earnings & Events

Webcasts

Last webcast

Sep 22, 2026

View

Performance

	5D	20D	120D	MTD	YTD
STVN	-6.4%	-2.2%	+35.8%	-4.4%	-0.4%
SPY	+1.2%	+0.6%	+11.6%	+1.6%	+13.6%
vs SPY	-7.6%	-2.8%	+24.2%	-6.0%	-14.0%

Key facts CIK 1849853 CUSIP T9224W109 13F (30d) 4 filings 4 filers Visit website Investor relations

STVN · Stevanato Group S.p.A.

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Versus peers

At a glance

Performance